Finnish AntiCoagulation in Atrial Fibrillation (FinACAF)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/39871
• EU PAS number:
  EUPAS29845
• Study ID:
  39871
• Official title and acronym:
  Finnish AntiCoagulation in Atrial Fibrillation (FinACAF)
• DARWIN EU® study:
  No
• Study countries:
  Finland
• Study status:
  Finalised

Research institution and networks

Institutions

Helsinki University Hospital (HYKS)

Turku University Hospital Turku, Finland, Aalto University Espoo, Finland

Study timelines

Date when funding contract was signed

Planned: 24/12/2018

Actual: 01/01/2019

Study start date

Planned: 02/09/2019

Actual: 02/09/2019

Data analysis start date

Planned: 01/01/2020

Date of final study report

Planned: 03/08/2020

Actual: 10/03/2021

Sources of funding

Non for-profit organisation (e.g. charity)

Other

More details on funding

EVO HUS, Koskelo foundation, Finnish foundation for cardiovascular research

Study protocol

Initial protocol

Tutkimussuunnitelma_FinACAF_21052015

Updated protocol

Tutkimussuunnitelma_FinACAF_02032021

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable